Angiocrine Bioscience

0 followers

‌

Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.

Industries

Headquarters

Stage

Employees

Links

Org chart

Paul Finnegan
CEO

Paul Finnegan

Collapse
John R. Jaskowiak
COO
John Lomoro
CFO
John K. Fraser
Chief Scientific Officer
Jeannette Filippone
General Counsel
Lee Landeen
Executive Director, Pre-clinical Development
Michael Ginsberg
Senior Director, Product Development
Margie Breneman
Senior Director, Project Management
Daniel J. Nolan
Director, External Research
Geoff Davis
President And CSO
Doreen G.
Vice President Medical Affairs
Gayle Bresnahan
Director, Clinical Operations
KP
Kathy K. Park
Associate Director Clinical Operations

Teams

+7

Leadership Team

10 members

+6

Board of Directors

9 members

+2

CEO and Executive Team

5 members

Founding Team

1 members

Similar companies

Dyno Therapeutics logo

Dyno Therapeutics

4 followers

BioMarin Pharmaceutical logo

BioMarin Pharmaceutical

21 followers

Adaptive Biotechnologies logo

Adaptive Biotechnologies

11 followers

Agilent Technologies logo

Agilent Technologies

60 followers

Regeneron logo

Regeneron

77 followers

Discover companies